Employment-Based Depot Naltrexone Clinical Trial
Employment-Based Depot Naltrexone Clinical Trial
批准号:
7659688
负责人:
Kenneth Silverman
金额:
$64.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2011-06-30
关键词:
AbstinenceAccountingAdherenceAdultAgonistBehaviorBehavior TherapyBuprenorphineCharacteristicsChronic DiseaseClinicalClinical TrialsCocaineDrug AddictionDrug FormulationsDrug Metabolic DetoxicationDrug abuseEconomicsEffectivenessEmployee Assistance Program (Health Care)EmploymentEvaluationGrowthHeroinHeroin DependenceIndividualInpatientsInstitutionInterventionMaintenanceMeasuresMedical EconomicsMethadoneModelingNaltrexoneNarcotic AntagonistsOpiate AddictionOpiatesOpioidOralOutcomeParticipantPatientsPharmaceutical PreparationsPharmacotherapyProceduresProviderPsychological reinforcementRandomizedResearchResearch PersonnelResistanceRiskRoleServicesSubstance abuse problemTherapeuticTherapeutic InterventionTimeUnemploymentUse EffectivenessWagesWorkWorkplaceaddictionbasebehavior changedrug abstinenceeffective therapymethadone maintenancenovelprogramsreinforcersocialtherapeutic effectivenessvolunteer
中文摘要
描述(由申请者提供):海洛因成瘾可造成破坏性的社会、医疗和经济后果。美沙酮维持是治疗海洛因成瘾的一种有效方法,但只有大约20%的阿片依赖者接受这种治疗。纳曲酮是一种阿片类拮抗剂,对许多人来说可能是一种有效的替代品。然而,由于患者接受性差,它的应用受到了限制。最近开发的纳曲酮缓释库制剂可提供长达6周的阿片拮抗作用,并简化纳曲酮的依从性。然而,考虑到大多数患者对口服纳曲酮的排斥反应,需要同时进行行为治疗,以鼓励患者持续服用该库。计划进行一项随机研究,以评估治疗工作场所在促进失业阿片依赖成年人使用纳曲酮方面的有效性。治疗工作场所是一种新型的基于就业的干预措施,它使用工作工资来加强临床上重要的行为改变;它已经在其他应用中被证明是有效的。在这个模范工作场所,药物滥用患者被雇佣并支付工资。为了促进令人满意的行为,薪酬既取决于工作,也取决于其他行为。自愿戒毒的成人将接受住院戒毒和纳曲酮诱导。完成诱导的参与者(N=80)将获得为期6个月的处方库纳曲酮,被邀请到治疗工作场所工作,并随机分配到两组中的一组,这两组在工作和赚取工资的偶然性方面将有所不同。处于“工作场所加纳曲酮应急”状态的患者将获得进入工作场所的机会,并通过每月服用一次纳曲酮仓库来赚取工资。“工作场所加纳曲酮处方”参与者将被鼓励服用仓库纳曲酮,但获得工作和赚取工资并不取决于是否这样做。将在为期6个月的试验中评估接受仓库纳曲酮和阿片剂使用的关键措施。
这项研究将对一种新的以就业为基础的干预措施--治疗工作场所--进行严格的评估,以促进纳曲酮仓库的使用,并促进海洛因依赖者的阿片类药物戒断,这些人有相当大的持续和长期阿片成瘾的风险。
英文摘要
DESCRIPTION (provided by applicant): Heroin addiction can have devastating social, medical and economic consequences. Methadone maintenance is an effective treatment for heroin addiction, but only about 20 percent of opiate dependent individuals receive it. Naltrexone is an opiate antagonist that could be an effective alternative for many individuals. However, its utility has been limited by poor patient acceptance. Recently developed extended-release depot formulations of naltrexone provide opiate antagonism for up to 6 weeks and simplify naltrexone adherence. However, given the rejection of oral naltrexone by most patients, concurrent behavioral treatment will be needed to encourage patients to take the depot consistently. A randomized study is planned to evaluate the effectiveness of the Therapeutic Workplace in promoting use of depot naltrexone in unemployed opiate-dependent adults. The Therapeutic Workplace is a novel employment based intervention that uses salary for work to reinforce clinically important behavior change; it has been shown effective in other applications. Drug abuse patients are hired and paid in this model workplace. To promote desirable behaviors, salary is made contingent both on work and on those other behaviors. Volunteer heroin dependent adults will be provided inpatient detoxification and naltrexone induction. Participants who complete the induction (N=80) will be prescribed depot naltrexone for 6 months, invited to work in the Therapeutic Workplace, and randomly assigned to one of two groups that will differ in the contingencies for working and earning salary. Patients in the "Workplace Plus Naltrexone Contingency" condition will earn access to the workplace and to earning salary by taking depot naltrexone once per month. "Workplace Plus Naltrexone Prescription" participants will be encouraged to take depot naltrexone, but access to working and earning salary will not be not contingent on doing so. Critical measures of acceptance of depot naltrexone and opiate use will be assessed over the 6-month trial.
This study will provide a rigorous evaluation of a novel employment-based intervention, the Therapeutic Workplace, to promote use of depot naltrexone and to promote opiate abstinence in heroin dependent individuals who are at considerable risk for persistent and long-term opiate addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long-Term Treatment of Opioid Use Disorder
-
批准号:10371356
-
项目类别:
-
资助金额:$68.28万
-
财政年份:2022
-
负责人:Kenneth Silverman
-
依托单位:
Long-Term Treatment of Opioid Use Disorder
-
批准号:10598546
-
项目类别:
-
资助金额:$61.72万
-
财政年份:2022
-
负责人:Kenneth Silverman
-
依托单位:
Incentives for Suppression of HIV-1 RNA in People Living with HIV
-
批准号:8846864
-
项目类别:
-
资助金额:$81.78万
-
财政年份:2015
-
负责人:Kenneth Silverman
-
依托单位:
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction
-
批准号:9220802
-
项目类别:
-
资助金额:$65.87万
-
财政年份:2015
-
负责人:Kenneth Silverman
-
依托单位:
Incentives for Suppression of HIV-1 RNA in People Living with HIV
-
批准号:9194382
-
项目类别:
-
资助金额:$74.09万
-
财政年份:2015
-
负责人:Kenneth Silverman
-
依托单位:
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users
-
批准号:7501320
-
项目类别:
-
资助金额:$62.95万
-
财政年份:2007
-
负责人:Kenneth Silverman
-
依托单位:
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users
-
批准号:8081710
-
项目类别:
-
资助金额:$63.91万
-
财政年份:2007
-
负责人:Kenneth Silverman
-
依托单位:
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users
-
批准号:7643431
-
项目类别:
-
资助金额:$63.55万
-
财政年份:2007
-
负责人:Kenneth Silverman
-
依托单位:
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users
-
批准号:7848886
-
项目类别:
-
资助金额:$64.38万
-
财政年份:2007
-
负责人:Kenneth Silverman
-
依托单位:
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users
-
批准号:7339450
-
项目类别:
-
资助金额:$68.77万
-
财政年份:2007
-
负责人:Kenneth Silverman
-
依托单位:
Employment-Based Addiction Pharmacotherapy
-
批准号:6852277
-
项目类别:
-
资助金额:$62.35万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-based Depot Naltrexone Clinical Trial
-
批准号:8600664
-
项目类别:
-
资助金额:$61.51万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-Based Depot Naltrexone Clinical Trial
-
批准号:7127187
-
项目类别:
-
资助金额:$64.95万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-Based Addiction Pharmacotherapy
-
批准号:7393837
-
项目类别:
-
资助金额:$62.32万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-based Depot Naltrexone Clinical Trial
-
批准号:8261564
-
项目类别:
-
资助金额:$67.35万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-Based Addiction Pharmacotherapy
-
批准号:7220582
-
项目类别:
-
资助金额:$62.06万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-based Depot Naltrexone Clinical Trial
-
批准号:8790436
-
项目类别:
-
资助金额:$60.58万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-based Depot Naltrexone Clinical Trial
-
批准号:8416374
-
项目类别:
-
资助金额:$59.05万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-Based Addiction Pharmacotherapy
-
批准号:7046722
-
项目类别:
-
资助金额:$62.38万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
Employment-Based Addiction Pharmacotherapy
-
批准号:7600617
-
项目类别:
-
资助金额:$63.87万
-
财政年份:2005
-
负责人:Kenneth Silverman
-
依托单位:
海外基金